Outset Medical (OM) Stock: Buy, Sell, or Hold?
OM - Outset Medical, Inc. Common Stock
$3.21
-0.06 (-1.83%)
▼
5d:
-9.96%
30d:
-28.67%
90d:
-25.35%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When OM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OM shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OM is currently trading at $3.21, which is considered oversold relative to its 30-day fair value range of $3.61 to $4.77.
Technical Outlook: Technically, OM is showing sideways momentum. The price is currently testing key support at $3.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OM scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.67 (+138.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OM is showing sideways momentum. The price is currently testing key support at $3.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OM scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.67 (+138.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.61 -
$4.77
Company Quality Score
43/100
(HOLD)
Options IV Signal
40th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 40th percentile)
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 138.8% below Wall St target ($7.67)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.61 -
$4.77
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.15
(35.7%)
Support & Resistance Levels
Support Level
$3.20
Resistance Level
$4.18
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.40
Wall Street Target
$7.67
(+138.8%)
Revenue Growth (YoY)
0.7%
Profit Margin
-63.1%
Share & Embed Analysis
Last updated: September 12, 2026 8:24 AM ET
Data refreshes hourly during market hours. Next update: 9:24 AM
Data refreshes hourly during market hours. Next update: 9:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
